Menopausal Hormone Therapy: Overuse or Essential Care? A Critical Appraisal of The Lancet’s Perspective
A recent Lancet article has reignited debate over the role of Menopausal Hormone Therapy (MHT) in managing menopause symptoms. The publication argues that menopause is being over-medicalized, with MHT prescribed too frequently, sometimes without sufficient consideration of alternative approaches. While this perspective raises important points, it also warrants a balanced critique.
The Argument Against Overuse
The Lancet article suggests that menopause is increasingly treated as a hormone deficiency disease, rather than a natural life stage. Researchers argue that:
-
-
- Commercial interests may be influencing MHT prescriptions.
- The media often portrays menopause negatively, emphasizing extreme symptoms.
- Women may be over-reliant on MHT, rather than exploring lifestyle changes or non-hormonal therapies.
-
This perspective challenges the dominant narrative that MHT is the primary solution for menopause-related discomfort.
Counterarguments: The Case for MHT
While concerns about over-medicalization are valid, dismissing MHT as unnecessary oversimplifies the issue. Many women experience debilitating symptoms that significantly impact their quality of life, including:
-
-
- Severe hot flashes and night sweats
- Mood disturbances and cognitive decline
- Increased risk of osteoporosis and cardiovascular disease
-
For these women, MHT can be life-changing, improving sleep, mood, and overall well- being. Additionally, body-identical transdermal MHT has been shown to be safe and effective, with minimal risks compared to older synthetic hormone therapies.
Finding the Balance
Rather than framing MHT as overused or unnecessary, the conversation should focus on:
-
-
- Individualized treatment—not all women need MHT, but some benefit greatly.
- Accurate risk assessment—understanding the real risks of MHT, rather than relying
on outdated studies. - Holistic approaches—combining diet, exercise, psychological support, and medical treatment when necessary.
-
Final Thoughts
The Lancet article raises important concerns about the commercialization of menopause treatment, but it risks downplaying the genuine suffering many women experience. The best approach is personalized care, where women are empowered with accurate information to make informed decisions about their health.
What’s your take—do you think menopause is being over-medicalized, or is MHT an essential tool for managing symptoms? Lets discuss!
